Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 169 to 170 of 170 entries
Sorted by: Best Match Show Resources per page
Spine surgery and fat embolism syndrome. Defining the boundaries of medical accountability by hospital autopsy.

Frontiers in bioscience (Landmark edition)

Radaelli D, Zanon M, Concato M, Fattorini P, Alfieri L, Marino R, Neri M, Cipolloni L, D'Errico S.
PMID: 34994188
Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1760-1768. doi: 10.52586/5067.

BACKGROUND: Fat Embolism Syndrome (FES) is a clinical condition characterized by neurological, respiratory, hematological and cutaneous manifestations. Fatal FES has been described as a rare complication during or after spinal elective surgery. The investigation of the cause of death...

Cite
Radaelli D, Zanon M, Concato M, et al. Spine surgery and fat embolism syndrome. Defining the boundaries of medical accountability by hospital autopsy. Front Biosci (Landmark Ed). 2021;26(12):1760-1768doi: 10.52586/5067.
Radaelli, D., Zanon, M., Concato, M., Fattorini, P., Alfieri, L., Marino, R., Neri, M., Cipolloni, L., & D'Errico, S. (2021). Spine surgery and fat embolism syndrome. Defining the boundaries of medical accountability by hospital autopsy. Frontiers in bioscience (Landmark edition), 26(12), 1760-1768. https://doi.org/10.52586/5067
Radaelli, Davide, et al. "Spine surgery and fat embolism syndrome. Defining the boundaries of medical accountability by hospital autopsy." Frontiers in bioscience (Landmark edition) vol. 26,12 (2021): 1760-1768. doi: https://doi.org/10.52586/5067
Radaelli D, Zanon M, Concato M, Fattorini P, Alfieri L, Marino R, Neri M, Cipolloni L, D'Errico S. Spine surgery and fat embolism syndrome. Defining the boundaries of medical accountability by hospital autopsy. Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1760-1768. doi: 10.52586/5067. PMID: 34994188.
Copy Download .nbib Format: NLM
Recent Advances in Biotransformation by Cunninghamella Species.

Current drug metabolism

Gonçalves MD, Tomiotto-Pellissier F, de Matos RLN, Assolini JP, da Silva Bortoleti BT, Concato VM, Silva TF, Rafael JA, Pavanelli WR, Conchon-Costa I, Arakawa NS.
PMID: 34825868
Curr Drug Metab. 2021;22(13):1035-1064. doi: 10.2174/1389200222666211126100023.

The goal of the biotransformation process is to develop structural changes and generate new chemical compounds, which can occur naturally in mammalian and microbial organisms, such as filamentous fungi, and represent a tool to achieve enhanced bioactive compounds. Cunninghamella...

Cite
Gonçalves MD, Tomiotto-Pellissier F, de Matos RLN, et al. Recent Advances in Biotransformation by Cunninghamella Species. Curr Drug Metab. 2021;22(13):1035-1064doi: 10.2174/1389200222666211126100023.
Gonçalves, M. D., Tomiotto-Pellissier, F., de Matos, R. L. N., Assolini, J. P., da Silva Bortoleti, B. T., Concato, V. M., Silva, T. F., Rafael, J. A., Pavanelli, W. R., Conchon-Costa, I., & Arakawa, N. S. (2021). Recent Advances in Biotransformation by Cunninghamella Species. Current drug metabolism, 22(13), 1035-1064. https://doi.org/10.2174/1389200222666211126100023
Gonçalves, Manoela Daiele, et al. "Recent Advances in Biotransformation by Cunninghamella Species." Current drug metabolism vol. 22,13 (2021): 1035-1064. doi: https://doi.org/10.2174/1389200222666211126100023
Gonçalves MD, Tomiotto-Pellissier F, de Matos RLN, Assolini JP, da Silva Bortoleti BT, Concato VM, Silva TF, Rafael JA, Pavanelli WR, Conchon-Costa I, Arakawa NS. Recent Advances in Biotransformation by Cunninghamella Species. Curr Drug Metab. 2021;22(13):1035-1064. doi: 10.2174/1389200222666211126100023. PMID: 34825868.
Copy Download .nbib Format: NLM
Showing 169 to 170 of 170 entries